Fig. 2: Overall survival of patients with myeloid neoplasm based on presence or lack of ZRSR2 mutation and other co-mutations.
From: Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms
A Overall survival for 164 ZRSR2m MN patients (with dotted red line showing median OS). B OS of ZRSR2m vs ZRSRwt in MDS patients. C OS according to the presence of an isolated TET2 co-mutation in ZRSR2m MN patients.
